Summary
This cross-over study was conducted to compare serum phenytoin levels after chronic ingestion of phenytoin tablets with or without previous chewing. The phenytoin therapy was administered as 50 mg chewable Infatabs® tablets in a single morning dose of 200 mg. There was no significant difference between the two modes of ingestion as regards serum phenytoin levels measured at various times after ingestion of the phenytoin tablets. Moreover, the area under the curve did not differ significantly during the 24 h interval. Minor changes between two Dilantin® formulations, however, could influence drug availability.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Manson, J. I., Beal, S. M., Margarey, A., Pollard, A. C., O'Reilly, W. J., Sansom, L. N.: Bioavailability of phenytoin from various pharmaceutical preparations in children. Med. J. Aust.2, 590–592 (1975)
Pentikainen, P. J., Neuvonen, P. J., Elfving, S. M.: Bioavailability of four brands of phenytoin tablets. Europ. J. Clin. Pharmacol.9, 213–218 (1975)
Rambeck, B., Boenigk, H. E., Stenzel, E.: Bioavailability of three phenytoin preparations in healthy subjects and in epileptics. Europ. J. Clin. Pharmacol.12, 285–290 (1977)
Lund, L.: Clinical significance of generic inequivalence of three different pharmaceutical preparations of phenytoin. Europ. J. Clin. Pharmacol.7, 119–124 (1974)
Johansen, H. E., Wiese, C. F.: The influence of particle size and other technological factors on the absorption and in vitro dissolution rate of phenytoin from tablets. Arch. Pharmacol. Chem.127, 243–250 (1970)
Smith, Th. C., Kinkel, A.: Absorption and metabolism of phenytoin from tablets and capsules. Clin. Pharm. Ther.20, 738–742 (1976)
Bielmann, P., Levac, T.: Can phenytoin be gradually withdrawn in patients with major motor epilepsy maintained on clonazepam and phenobarbital? Current Ther. Res.23, 253–259 (1978)
Lee, S. I., Bass, N. H.: Microassay of diphenylhydantoin. Blood and regional brain concentration in rats during acute intoxication. Neurology20, 115–124 (1970)
Lindquist, E. F.: Design and Analysis of Experiments in Psychology and Education, p. 273–281. Boston: Houghton Mifflin 1956
Siegel, S.: Non parametric Statistics for the Behavioural Sciences, p. 75–83. New-York: McGraw-Hill 1956
Glazko, A. J., Chang, T.: Diphenylhydantoin, Absorption, Distribution and Excretion. In: Antiepileptic Drugs. Woodbury, D. M., Penry, J. K. and Schmidt, R. P. (eds.), p. 127–148. New York: Raven Press 1972
Eadie, M. J., Sutherland, J. M., Tyrer, J. H.: “Dilantin” overdosage. Med. J. Aust.2, 515 (1968)
Rail, L.: “Dilantin” overdosage. Med. J. Aust.2, 329 (1968)
Dissolution: in: U. S. Pharmacopea XIX, p. 934
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Bielmann, P., Levac, T. Comparison of serum phenytoin levels in epileptic patients who swallowed their phenytoin tablets with or without previous chewing. Eur J Clin Pharmacol 14, 191–194 (1978). https://doi.org/10.1007/BF02089959
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF02089959